Federation des caisses Desjardins du Quebec’s Tvardi Therapeutics TVRD Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-21	Closed	-$9.91K	–	2284
2020 Q1	$9.91K	Hold	21	–	–	﹤0.01%	1676
2019 Q4	$12.1K	Hold	21	–	–	﹤0.01%	1845
2019 Q3	$13.7K	Hold	21	–	–	﹤0.01%	1753
2019 Q2	$16.1K	Hold	21	–	–	﹤0.01%	1736
2019 Q1	$14.7K	Hold	21	–	–	﹤0.01%	1579
2018 Q4	$9.75K	Hold	21	–	–	﹤0.01%	1630
2018 Q3	$18K	Hold	21	–	–	﹤0.01%	1585
2018 Q2	$14.4K	Hold	21	–	–	﹤0.01%	1656
2018 Q1	$9.29K	Hold	21	–	–	﹤0.01%	1734
2017 Q4	$9.18K	Hold	21	–	–	﹤0.01%	1731
2017 Q3	$10.3K	Hold	21	–	–	﹤0.01%	1669
2017 Q2	$11.5K	Hold	21	–	–	﹤0.01%	1695
2017 Q1	$13.8K	Buy	+21	New	+$11.2K	﹤0.01%	1367

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TVRD Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Tvardi Therapeutics (TVRD) in Q2 2020, closing a stake of 21 shares — an estimated $9.91K sold.

Federation des caisses Desjardins du Quebec first reported a position in TVRD in Q1 2017 and held it in 13 quarters. The position peaked at $18K in Q3 2018. 146 funds tracked by Wall St. Rank hold TVRD as of Q2 2020.

Federation des caisses Desjardins du Quebec reported no remaining Tvardi Therapeutics position as of Q2 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 21 Tvardi Therapeutics shares in Q2 2020, an estimated $9.91K.
Federation des caisses Desjardins du Quebec first reported a position in Tvardi Therapeutics in Q1 2017 and held it in 13 quarters.
Federation des caisses Desjardins du Quebec's Tvardi Therapeutics position peaked at $18K in Q3 2018.
146 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.